73
Views
2
CrossRef citations to date
0
Altmetric
REVIEWS

Pediatric Obesity: Parallels with Addiction and Treatment Recommendations

, PhD, , MD & , MD
Pages 80-96 | Received 12 Jun 2007, Accepted 18 Oct 2007, Published online: 03 Jul 2009

REFERENCES

  • Ogden C L. Defining overweight in children using growth charts. Md Med 2004; 5: 19–21
  • Dietz W H. Health consequences of obesity in youth: childhood predictors of adult disease. Pediatrics 1998; 101: 518–25
  • Williams C L, Hayman L L, Daniels S R, Robinson T N, Steinberger J, Paridon S, Bazzarre T. Cardiovascular health in childhood: a statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2002; 106: 143–60
  • Dorsey K B, Wells C, Krumholz H M, Concato J C. Diagnosis, evaluation, and treatment of childhood obesity in pediatric practice. Arch Pediatr Adolesc Med 2005; 159: 632–8
  • Fowler-Brown A, Kahwati L C. Prevention and treatment of overweight in children and adolescents. Am Fam Physician 2004; 69: 2591–8
  • American Dietetic Association. Position of the American Dietetic Association: Individual-, Family-, School-, and Community-Based Interventions for Pediatric Overweight. ADA. 2006, http://www.eatright.org/ada/files/Familynp.pdf
  • U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. Prevalence of Overweight Among Children and Adolescents: United States. 1999–2002, http://www.cdc.gov/nchs/products/pubs/pubd/hestats/overwght99.htm
  • Hedley A A, Ogden C L, Johnson C L, Carroll M D, Curtin L R, Flegal K M. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA 2004; 291: 2847–50
  • Ogden C L, Flegal K M, Carroll M D, Johnson C L. Prevalence and trends in overweight among US children and adolescents, 1999–2000. JAMA 2002; 288: 1728–32
  • Patrick K, Norman G J, Calfas K J, et al. Diet, physical activity, and sedentary behaviors as risk factors for overweight in adolescence. Arch Pediatr Adolesc Med 2004; 158: 385–90
  • Garn S M, Clark D C. Trends in fatness and the origins of obesity Ad Hoc Committee to Review the Ten-State Nutrition Survey. Pediatrics 1976; 57: 443–56
  • Charney E, Goodman H C, McBride M, Lyon B, Pratt R. Childhood antecedents of adult obesity. Do chubby infants become obese adults?. N Engl J Med 1976; 295: 6–9
  • Reaven G M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–607
  • Ogden C L, Carroll M D, Flegal K M. Epidemiologic trends in overweight and obesity. Endocrinol Metab Clin North Am 2003; 32: 741–60; vii
  • Gidding S S, Leibel R L, Daniels S, Rosenbaum M, Van Horn L, Marx G R. Understanding obesity in youth. A statement for healthcare professionals from the Committee on Atherosclerosis and Hypertension in the Young of the Council on Cardiovascular Disease in the Young and the Nutrition Committee, American Heart Association. Writing Group. Circulation 1996; 94: 3383–7
  • Cook S, Weitzman M, Auinger P, Nguyen M, Dietz W H. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med 2003; 157: 821–7
  • Caprio S. Insulin resistance in childhood obesity. J Pediatr Endocrinol Metab 2002; 15(suppl 1)487–92
  • Steinberger J. Insulin resistance and cardiovascular risk in the pediatric patient. Prog Pediatr Cardiol 2001; 12: 169–75
  • Weiss R, Dziura J, Burgert T S, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362–74
  • American Dietetic Association (ADA). Position of the American Dietetic Association, Dietitians of Canada, and the American College of Sports Medicine: nutrition and athletic performance. J Am Diet Assoc 2000; 100: 1543–56
  • Arslanian S. Type 2 diabetes in children: clinical aspects and risk factors. Horm Res 2002; 57(Suppl 1)19–28
  • Sabin M, Crowne E, Shield J. Childhood obesity and type 2 diabetes. Nurs Times 2002; 98: 49–50
  • Chang L Y, Li H Y, Wei J N, Chuang L M. Type 2 diabetes and obesity in children and adolescents: experience from studies in Taiwanese population. Curr Diabetes Rev 2006; 2: 185–93
  • Fagot-Campagna A, Pettitt D J, Engelgau M M, et al. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr 2000; 136: 664–72
  • Cruz M L, Shaibi G Q, Weigensberg M J, Spruijt-Metz D, Ball G D, Goran M I. Pediatric obesity and insulin resistance: chronic disease risk and implications for treatment and prevention beyond body weight modification. Annu Rev Nutr 2005; 25: 435–68
  • Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002; 346: 802–10
  • Gulekli B, Turhan N O, Senoz S, Kukner S, Oral H, Gokmen O. Endocrinological, ultrasonographic and clinical findings in adolescent and adult polycystic ovary patients: a comparative study. Gynecol Endocrinol 1993; 7: 273–7
  • Goran M I, Gower B A. Abdominal obesity and cardiovascular risk in children. Coron Artery Dis 1998; 9: 483–7
  • Must A, Jacques P F, Dallal G E, Bajema C J, Dietz W H. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 1992; 327: 1350–5
  • Berenson G S, Srinivasan S R, Bao W, Newman W P, 3rd, Tracy R E, Wattigney W A. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998; 338: 1650–6
  • Steinberger J, Daniels S R. Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation 2003; 107: 1448–53
  • Rosner B, Prineas R, Daniels S R, Loggie J. Blood pressure differences between blacks and whites in relation to body size among US children and adolescents. Am J Epidemiol 2000; 151: 1007–19
  • Sorof J, Daniels S. Obesity hypertension in children: a problem of epidemic proportions. Hypertension 2002; 40: 441–7
  • Falkner B, Gidding S S, Ramirez-Garnica G, Wiltrout S A, West D, Rappaport E B. The relationship of body mass index and blood pressure in primary care pediatric patients. J Pediatr 2006; 148: 195–200
  • Baldridge A D, Perez-Atayde A R, Graeme-Cook F, Higgins L, Lavine J E. Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J Pediatr 1995; 127: 700–4
  • Tominaga K, Kurata J H, Chen Y K, et al. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci 1995; 40: 2002–9
  • Rashid M, Roberts E A. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr 2000; 30: 48–53
  • Roberts E A. Nonalcoholic steatohepatitis in children. Curr Gastroenterol Rep 2003; 5: 253–9
  • O'Brien L M, Sitha S, Baur L A, Waters K A. Obesity increases the risk for persisting obstructive sleep apnea after treatment in children. Int J Pediatr Otorhinolaryngol 2006; 70: 1555–60
  • Taylor E D, Theim K R, Mirch M C, et al. Orthopedic complications of overweight in children and adolescents. Pediatrics 2006; 117: 2167–74
  • Kinugasa A, Tsunamoto K, Furukawa N, Sawada T, Kusunoki T, Shimada N. Fatty liver and its fibrous changes found in simple obesity of children. J Pediatr Gastroenterol Nutr 1984; 3: 408–14
  • Franzese A, Vajro P, Argenziano A, et al. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci 1997; 42: 1428–32
  • Strauss R S, Barlow S E, Dietz W H. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr 2000; 136: 727–33
  • Mustillo S, Worthman C, Erkanli A, Keeler G, Angold A, Costello E J. Obesity and psychiatric disorder: developmental trajectories. Pediatrics 2003; 111: 851–9, (4 pt 1)
  • Kolotkin R L, Crosby R D, Williams G R, Hartley G G, Nicol S. The relationship between health-related quality of life and weight loss. Obes Res 2001; 9: 564–71
  • Nammi S, Koka S, Chinnala K M, Boini K M. Obesity: an overview on its current perspectives and treatment options. Nutr J 2004; 3: 3
  • Hasler G, Buysse D J, Klaghofer R, et al. The association between short sleep duration and obesity in young adults: a 13-year prospective study. Sleep 2004; 27: 661–6
  • Sorbara M, Geliebter A. Body image disturbance in obese outpatients before and after weight loss in relation to race, gender, binge eating, and age of onset of obesity. Int J Eat Disord 2002; 31: 416–23
  • Eldredge K L, Agras W S. Weight and shape overconcern and emotional eating in binge eating disorder. Int J Eat Disord 1996; 19: 73–82
  • Jirik-Babb P, Geliebter A. Comparison of psychological characteristics of binging and nonbinging obese, adult, female outpatients. Eat Weight Disord 2003; 8: 173–7
  • Marcus B H, Selby V C, Niaura R S, Rossi J S. Self-efficacy and the stages of exercise behavior change. Res Q Exerc Sport 1992; 63: 60–6
  • Wilfley D E. An analysis of psychological distress, self-concept and patterns of family interactions in two subgroups of bulimia-normal weight and obese. Diss Abstr Int 1990; 50(11-B)5303
  • Strober M, Freeman R, Bower S, Rigali J. Binge eating in anorexia nervosa predicts later onset of substance use disorder. A ten-year prospective, longitudinal follow-up of 95 adolescents. J Youth Adolesc 1996; 25: 519–32
  • Zaider T, Johnson J G, Cockell S J. Psychiatric disorders associated with the onset and persistence of bulimia nervosa and binge eating disorder during adolescence. J Youth Adolesc 2002; 31: 319–29
  • Wang G J, Volkow N D, Thanos P K, Fowler J S. Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review. J Addict Dis 2004; 23: 39–53
  • Friedman J M. The function of leptin in nutrition, weight, and physiology. Nutr Rev 2002; 60: S1–14, (10 pt 2); discussion S68–84, 85–7
  • Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656–60
  • Tschop M, Smiley D L, Heiman M L. Ghrelin induces adiposity in rodents. Nature 2000; 407: 908–13
  • Wren A M, Seal L J, Cohen M A, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001; 86: 5992
  • Olszewski P K, Li D, Grace M K, Billington C J, Kotz C M, Levine A S. Neural basis of orexigenic effects of ghrelin acting within lateral hypothalamus. Peptides 2003; 24: 597–602
  • Date Y, Murakami N, Toshinai K, et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002; 123: 1120–8
  • Tschop M, Weyer C, Tataranni P A, Devanarayan V, Ravussin E, Heiman M L. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001; 50: 707–9
  • Hansen T K, Dall R, Hosoda H, et al. Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol (Oxf) 2002; 56: 203–6
  • Geliebter A, Yahav E K, Gluck M E, Hashim S A. Gastric capacity, test meal intake, and appetitive hormones in binge eating disorder. Physiol Behav 2004; 81: 735–40
  • Geliebter A. Weight loss and plasma ghrelin levels. N Engl J Med 2002; 347: 1379–81, author reply 1379–81
  • Shiiya T, Nakazato M, Mizuta M, et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 2002; 87: 240–4
  • Goldstone A P, Thomas E L, Brynes A E, et al. Elevated fasting plasma ghrelin in prader-willi syndrome adults is not solely explained by their reduced visceral adiposity and insulin resistance. J Clin Endocrinol Metab 2004; 89: 1718–26
  • Matsuda M, Liu Y, Mahankali S, et al. Altered hypothalamic function in response to glucose ingestion in obese humans. Diabetes 1999; 48: 1801–6
  • James G A, Gold M S, Liu Y. Interaction of satiety and reward response to food stimulation. J Addict Dis 2004; 23: 23–37
  • James G A, Guo W, Liu Y. Imaging in vivo brain-hormone interaction in the control of eating and obesity. Diabetes Technol Ther 2001; 3: 617–22
  • Liu Y L, Sennitt M V, Hislop D C, Crombie D L, Heyman R A, Cawthorne M A. Retinoid X receptor agonists have anti-obesity effects and improve insulin sensitivity in Zucker fa/fa rats. Int J Obes Relat Metab Disord 2000; 24: 997–1004
  • Hill J O, Wyatt H R, Reed G W, Peters J C. Obesity and the environment: where do we go from here?. Science 2003; 299: 853–5
  • Hill J O, Peters J C. Environmental contributions to the obesity epidemic. Science 1998; 280: 1371–4
  • Connolly J, Gargiula L, Reeve D. Selections from current literature. Treatment issues in childhood obesity. Fam Pract 2002; 19: 304–9
  • Brownell K D, Wadden T A. Etiology and treatment of obesity: understanding a serious, prevalent, and refractory disorder. J Consult Clin Psychol 1992; 60: 505–17
  • Marshall S J, Biddle S J, Gorely T, Cameron N, Murdey I. Relationships between media use, body fatness and physical activity in children and youth: a meta-analysis. Int J Obes Relat Metab Disord 2004; 28: 1238–46
  • Jonas J M, Gold M S. Cocaine abuse and eating disorders. Lancet 1986; 1: 390–1
  • Eating disorders, M S Gold, C R Johnson, K Stennie. Lippincott, Williams & Wilkins, Philadelphia 1997
  • Volkow N D, Wise R A. How can drug addiction help us understand obesity?. Nat Neurosci 2005; 8: 555–60
  • Kendler K S, Thornton L M, Pedersen N L. Tobacco consumption in Swedish twins reared apart and reared together. Arch Gen Psychiatry 2000; 57: 886–92
  • Uhl G R, Liu Q R, Naiman D. Substance abuse vulnerability loci: converging genome scanning data. Trends Genet 2002; 18: 420–5
  • Baessler A, Hasinoff M J, Fischer M, et al. Genetic linkage and association of the growth hormone secretagogue receptor (ghrelin receptor) gene in human obesity. Diabetes 2005; 54: 259–67
  • Gautier J F, Chen K, Salbe A D, et al. Differential brain responses to satiation in obese and lean men. Diabetes 2000; 49: 838–46
  • Noble E P. Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review. Eur Psychiatry 2000; 15: 79–89
  • Blum K, Sheridan P J, Wood R C, Braverman E R, Chen T J, Comings D E. Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour. Pharmacogenetics 1995; 5: 121–41
  • Kleiner K D, Gold M S, Frost-Pineda K, Lenz-Brunsman B, Perri M G, Jacobs W S. Body mass index and alcohol use. J Addict Dis 2004; 23: 105–18
  • Kalra S P, Kalra P S. Overlapping and interactive pathways regulating appetite and craving. J Addict Dis 2004; 23: 5–21
  • Kalra S P, Dube M G, Pu S, Xu B, Horvath T L, Kalra P S. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 1999; 20: 68–100
  • Thiele T E, Navarro M, Sparta D R, Fee J R, Knapp D J, Cubero I. Alcoholism and obesity: overlapping neuropeptide pathways?. Neuropeptides 2003; 37: 321–37
  • Lindblom J, Wikberg J E, Bergstrom L. Alcohol-preferring AA rats show a derangement in their central melanocortin signalling system. Pharmacol Biochem Behav 2002; 72: 491–6
  • Belknap J K, Crabbe J C, Young E R. Voluntary consumption of ethanol in 15 inbred mouse strains. Psychopharmacology (Berl) 1993; 112: 503–10
  • Navarro M, Cubero I, Knapp D J, Thiele T E. MTII-induced reduction of voluntary ethanol drinking is blocked by pretreatment with AgRP-(83-132). Neuropeptides 2003; 37: 338–44
  • Schwartz M W, Baskin D G, Bukowski T R, et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996; 45: 531–5
  • Thiele T E, Miura G I, Marsh D J, Bernstein I L, Palmiter R D. Neurobiological responses to ethanol in mutant mice lacking neuropeptide Y or the Y5 receptor. Pharmacol Biochem Behav 2000; 67: 683–91
  • Thiele T E, Naveilhan P, Ernfors P. Assessment of ethanol consumption and water drinking by NPY Y(2) receptor knockout mice. Peptides 2004; 25: 975–83
  • Kiefer F, Jahn H, Kellner M, Naber D, Wiedemann K. Leptin as a possible modulator of craving for alcohol. Arch Gen Psychiatry 2001; 58: 509–10
  • Kiefer F, Jahn H, Schick M, Wiedemann K. Alcohol intake, tumour necrosis factor-alpha, leptin and craving: factors of a possibly vicious circle?. Alcohol Alcohol 2002; 37: 401–4
  • Malcher-Lopes R, Di S, et al. Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release. J Neurosci 2006; 26: 6643–50
  • Howlett A C, Breivogel C S, Childers S R, Deadwyler S A, Hampson R E, Porrino L J. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 2004; 47(suppl 1)345–58
  • Freund T F, Katona I, Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 2003; 83: 1017–66
  • Di Marzo V, Goparaju S K, Wang L, et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001; 410: 822–5
  • Kirkham T C, Williams C M, Fezza F, Di Marzo V. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 2002; 136: 550–7
  • Kirkham T C. Endocannabinoids in the regulation of appetite and body weight. Behav Pharmacol 2005; 16: 297–313
  • Cheer J F, Wassum K M, Heien M L, Phillips P E, Wightman R M. Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats. J Neurosci 2004; 24: 4393–400
  • Van Gaal L F, Rissanen A M, Scheen A J, Ziegler O, Rossner S. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 2005; 365: 1389–97
  • Kelley A E, Bakshi V P, Haber S N, Steininger T L, Will M J, Zhang M. Opioid modulation of taste hedonics within the ventral striatum. Physiol Behav 2002; 76: 365–77
  • Robbins T W, Everitt B J. Neurobehavioural mechanisms of reward and motivation. Curr Opin Neurobiol 1996; 6: 228–36
  • Kelley A E. Functional specificity of ventral striatal compartments in appetitive behaviors. Ann N Y Acad Sci 1999; 877: 71–90
  • Schultz W, Dayan P, Montague P R. A neural substrate of prediction and reward. Science 1997; 275: 1593–9
  • Di Chiara G. A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use. J Psychopharmacol 1998; 12: 54–67
  • Koob G F, Nestler E J. The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci 1997; 9: 482–97
  • Nestler E J, Aghajanian G K. Molecular and cellular basis of addiction. Science 1997; 278: 58–63
  • Dawe S, Loxton N J. The role of impulsivity in the development of substance use and eating disorders. Neurosci Biobehav Rev 2004; 28: 343–51
  • Davis C, Levitan R D, Muglia P, Bewell C, Kennedy J L. Decision-making deficits and overeating: a risk model for obesity. Obes Res 2004; 12: 929–35
  • Heatherton T F, Baumeister R F. Binge eating as escape from self-awareness. Psychol Bull 1991; 110: 86–108
  • Loxton N J, Dawe S. Alcohol abuse and dysfunctional eating in adolescent girls: the influence of individual differences in sensitivity to reward and punishment. Int J Eat Disord 2001; 29: 455–62
  • Hollander E, Wong C M. Obsessive-compulsive spectrum disorders. J Clin Psychiatry 1995; 56(suppl 4)3–6, discussion 53-5
  • Oldham J M, Hollander E, Skodol A E. Impulsivity and compulsivity. American Psychiatric Press, Washington, DC 1996
  • Matsunaga H, Kiriike N, Matsui T, Oya K, Okino K, Stein D J. Impulsive disorders in Japanese adult patients with obsessive-compulsive disorder. Compr Psychiatry 2005; 46: 43–9
  • Favazza A R, Simeon D. Self-mutilation. John Wiley & Sons, SussexEngland 1995
  • Lacey J H, Evans C D. The impulsivist: a multi-impulsive personality disorder. Br J Addict 1986; 81: 641–9
  • McElroy S L, Keck P E, Jr., Phillips K A. Kleptomania, compulsive buying, and binge-eating disorder. J Clin Psychiatry 1995; 56(suppl 4)14–26, discussion 27
  • Rasmussen S A, Eisen J L. The epidemiology and differential diagnosis of obsessive compulsive disorder. J Clin Psychiatry 1994; 55(suppl)5–10, discussion 11–4
  • Hsu L K, Kaye W, Weltzin T. Are the eating disorders related to obsessive compulsive disorder?. Int J Eat Disord 1993; 14: 305–18
  • McElroy S L, Hudson J I, Pope H, Jr, Keck P E, Jr, Aizley H G. The DSM-III-R impulse control disorders not elsewhere classified: clinical characteristics and relationship to other psychiatric disorders. Am J Psychiatry 1992; 149: 318–27
  • Newton J R, Freeman C P, Munro J. Impulsivity and dyscontrol in bulimia nervosa: is impulsivity an independent phenomenon or a marker of severity?. Acta Psychiatr Scand 1993; 87: 389–94
  • Raymond N C, Eckert E D, Hamalainen M, Evanson D, Thuras P D, Hartman B K, Faris P L. A preliminary report on pain thresholds in bulimia nervosa during a bulimic episode. Compr Psychiatry 1999; 40: 229–33
  • Espelage D L, Mazzeo S E, Sherman R, Thompson R. MCMI-II profiles of women with eating disorders: a cluster analytic investigation. J Personal Disord 2002; 16: 453–63
  • Engel S G, Corneliussen S J, Wonderlich S A, et al. Impulsivity and compulsivity in bulimia nervosa. Int J Eat Disord 2005; 38: 244–51
  • Favaro A, Zanetti T, Tenconi E, et al. The relationship between temperament and impulsive behaviors in eating disordered subjects. Eat Disord 2005; 13: 61–70
  • Carrasco J L, Diaz-Marsa M, Hollander E, Cesar J, Saiz-Ruiz J. Decreased platelet monoamine oxidase activity in female bulimia nervosa. Eur Neuropsychopharmacol 2000; 10: 113–7
  • Steiger H, Young S N, Kin N M, et al. Implications of impulsive and affective symptoms for serotonin function in bulimia nervosa. Psychol Med 2001; 31: 85–95
  • Cloninger C R, Svrakic D M, Przybeck T R. A psychobiological model of temperament and character. Arch Gen Psychiatry 1993; 50: 975–90
  • Fineberg N A, Roberts A, Montgomery S A, Cohen P J. Brain 5-HT function in obsessive-compulsive disorder; prolactin responses to d-fenfluramine. Br J Psychiatry 1998; 171: 280–2
  • Weintraub D, Potenza M N. Impulse control disorders in Parkinson's disease. Curr Neurol Neurosci Rep 2006; 6: 302–6
  • American Psychiatric Association. diagnostic and statistical manual of mental disorders. 4th ed. APA, Washington, DC 1994
  • Volkow N D, Fowler J S. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex 2000; 10: 318–25
  • Verdejo-Garcia A J, Perales J C, Perez-Garcia M. Cognitive impulsivity in cocaine and heroin polysubstance abusers. Addict Behav 2007; 32: 950–66
  • Clark L, Robbins T W, Ersche K D, Sahakian B J. Reflection impulsivity in current and former substance users. Biol Psychiatry 2006; 60: 515–22
  • Jentsch J D, Taylor J R. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) 1999; 146: 373–90
  • Barlow S E, Dietz W H. Obesity evaluation and treatment: Expert Committee recommendations. The Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services. Pediatrics 1998; 102: E29
  • Jelalian E, Saelens B E. Empirically supported treatments in pediatric psychology: pediatric obesity. J Pediatr Psychol 1999; 24: 223–48
  • Summerbell C D, Ashton V, Campbell K J, Edmunds L, Kelly S, Waters E. Interventions for treating obesity in children. Cochrane Database Syst Rev 2003, CD001872
  • Stuart W P, Broome M E, Smith B A, Weaver M. An integrative review of interventions for adolescent weight loss. J Sch Nurs 2005; 21: 77–85
  • Saelens B E, Sallis J F, Wilfley D E, Patrick K, Cella J A, Buchta R. Behavioral weight control for overweight adolescents initiated in primary care. Obes Res 2002; 10: 22–32
  • Sondike S B, Copperman N, Jacobson M S. Effects of a low-carbohydrate diet on weight loss and cardiovascular risk factor in overweight adolescents. J Pediatr 2003; 142: 253–8
  • Freemark M, Bursey D. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics 2001; 107: E55
  • Sasaki J, Shindo M, Tanaka H, Ando M, Arakawa K. A long-term aerobic exercise program decreases the obesity index and increases the high density lipoprotein cholesterol concentration in obese children. Int J Obes 1987; 11: 339–45
  • Epstein L H, Wing R R, Valoski A, Penner B C. Stability of food preferences during weight control. A study with 8- to 12-year-old children and their parents. Behav Modif 1987; 11: 87–101
  • Kirschenbaum D S, Harris E S, Tomarken A J. Effects of parental involvement in behavioral weight loss therapy for preadolescents. Behav Ther 1984; 15: 485–500
  • Epstein L H, Wing R R, Koeske R, Valoski A. Effects of diet plus exercise on weight change in parents and children. J Consult Clin Psychol 1984; 52: 429–37
  • Epstein L H, Wing R R, Penner B C, Kress M J. Effect of diet and controlled exercise on weight loss in obese children. J Pediatr 1985; 107: 358–61
  • Gutin B, Barbeau P, Owens S, et al. Effects of exercise intensity on cardiovascular fitness, total body composition, and visceral adiposity of obese adolescents. Am J Clin Nutr 2002; 75: 818–26
  • Owens S, Gutin B, Allison J, et al. Effect of physical training on total and visceral fat in obese children. Med Sci Sports Exerc 1999; 31: 143–8
  • Reilly J J, McDowell Z C. Physical activity interventions in the prevention and treatment of paediatric obesity: systematic review and critical appraisal. Proc Nutr Soc 2003; 62: 611–9
  • Becque M D, Katch V L, Rocchini A P, Marks C R, Moorehead C. Coronary risk incidence of obese adolescents; reduction by exercise plus diet intervention. Pediatrics 1998; 81: 605–12
  • Epstein L H, Wing R R, Koeske R, Valoski A. Effects of diet plus exercise on weight change in parents and children. J Consult Clin Psychol 1984; 52: 429–37
  • Epstein L H, Saelens B E, Myers M D, Vito D. Effects of decreasing sedentary behaviors on activity choice in obese children. Health Psychol 1997; 16: 107–13
  • Rocchini A P, Katch V, Anderson J, et al. Blood pressure in obese adolescents: effect of weight loss. Pediatrics 1988; 82: 16–23
  • Epstein L H, Valoski A M, Kalarchian M A, McCurley J. Do children lose and maintain weight easier than adults: a comparison of child and parent weight changes from six months to ten years. Obes Res 1995; 3: 411–7
  • Muller M J, Mast M, Asbeck I, Langnase K, Grund A. Prevention of obesity—is it possible?. Obes Rev 2001; 2: 15–28
  • Robinson T N. Reducing children's television viewing to prevent obesity: a randomized controlled trial. JAMA 1999; 282: 1561–7
  • Gortmaker S L, Peterson K, Wiecha J, et al. Reducing obesity via a school-based interdisciplinary intervention among youth: Planet Health. Arch Pediatr Adolesc Med 1999; 153: 409–18
  • Epstein L H, Squires S. The Stoplight Diet for Children. An eight week program for parents and children. Little, Brown, Boston 1988
  • Kitzmann K M, Beech B M. Family-based interventions for pediatric obesity: methodological and conceptual challenges from family psychology. J Fam Psychol 2006; 20: 175–89
  • Golan M, Fainaru M, Weizman A. Role of behaviour modification in the treatment of childhood obesity with the parents as the exclusive agents of change. Int J Obes Relat Metab Disord 1998; 22: 1217–24
  • Eliakim A, Kaven G, Berger I, Friedland O, Wolach B, Nemet D. The effect of a combined intervention on body mass index and fitness in obese children and adolescents—a clinical experience. Eur J Pediatr 2002; 161: 449–54
  • Brownell K D, Kelman J H, Stunkard A J. Treatment of obese children with and without their mothers: changes in weight and blood pressure. Pediatrics 1983; 71: 515–23
  • Wadden T A, Van Itallie T B, Blackburn G L. Responsible and irresponsible use of very-low-calorie diets in the treatment of obesity. JAMA 1990; 263: 83–5
  • Nuutinen O, Knip M. Long-term weight control in obese children: persistence of treatment outcome and metabolic changes. Int J Obes Relat Metab Disord 1992; 16: 279–87
  • Epstein L H, Valoski A, Wing R R, McCurley J. Ten-year outcomes of behavioral family-based treatment for childhood obesity. Health Psychol 1994; 13: 373–83
  • Epstein L H, Valoski A, McCurley J. Effect of weight loss by obese children on long-term growth. Am J Dis Child 1993; 147: 1076–80
  • Epstein L H, Valoski A, Wing R R, McCurley J. Ten-year follow-up of behavioral, family-based treatment for obese children. JAMA 1990; 264: 2519–23
  • Israel A C, Guile C A, Baker J E, Silverman W K. An evaluation of enhanced self-regulation training in the treatment of childhood obesity. J Pediatr Psychol 1994; 19: 737–49
  • The Writing Group for the DISC Collaborative Research Group. Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol. The Dietary Intervention Study in Children (DISC). JAMA 1995; 273: 1429–35
  • Obarzanek E, Kimm S Y, Barton B A, et al. Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the Dietary Intervention Study in Children (DISC). Pediatrics 2001; 107: 256–64
  • Haddock C K, Shadish W R, Klesges R C, Stein R J. Treatments for childhood and adolescent obesity. Ann Behav Med 1994; 16: 235–44
  • Botvin G J, Cantlon A, Carter B J, Williams C L. Reducing adolescent obesity through a school health program. J Pediatr 1979; 95: 1060–3
  • Lansky D, Vance M A. School-based intervention for adolescent obesity: analysis of treatment, randomly selected control, and self-selected control subjects. J Consult Clin Psychol 1983; 51: 147–8
  • Nuutinen O. Long-term effects of dietary counselling on nutrient intake and weight loss in obese children. Eur J Clin Nutr 1991; 45: 287–97
  • Foster G D, Wadden T A, Brownell K D. Peer-led program for the treatment and prevention of obesity in the schools. J Consult Clin Psychol 1985; 53: 538–40
  • Braet C, Tanghe A, Bode P D, Franckx H, Winckel M V. Inpatient treatment of obese children: a multicomponent programme without stringent calorie restriction. Eur J Pediatr 2003; 162: 391–6
  • Graves T, Meyers A W, Clark L. An evaluation of parental problem-solving training in the behavioral treatment of childhood obesity. J Consult Clin Psychol 1988; 56: 246–50
  • Epstein L H, Paluch R A, Gordy C C, Saelens B E, Ernst M M. Problem solving in the treatment of childhood obesity. J Consult Clin Psychol 2000; 68: 717–21
  • Hettema J M, Steele J, Miller W R. Motivational interviewing. Ann Rev Clin Psychol 2005; 1: 91–111
  • Rubak S, Sandbaek A, Lauritzen T, Christensen B. Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract 2005; 55: 305–12
  • Colby S M, Monti P M, Barnett N P, et al. Brief motivational interviewing in a hospital setting for adolescent smoking: a preliminary study. J Consult Clin Psychol 1998; 66: 574–8
  • Monti P M, Colby S M, Barnett N P, et al. Brief intervention for harm reduction with alcohol-positive older adolescents in a hospital emergency department. J Consult Clin Psychol 1999; 67: 989–94
  • Stephens R S, Roffman R A, Curtin L. Comparison of extended versus brief treatments for marijuana use. J Consult Clin Psychol 2000; 68: 898–908
  • Gordis E, Fuller R. Project MATCH. Addiction 1999; 94: 57–9
  • Match P. Project MATCH Research. Matching alcoholism treatments to client hetergeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol 1997; 58: 7–29
  • Miller W R. Enhancing motivation for change in substance abuse treatment. Center for Substance Abuse Treatment, Rockville, MD 1999, [Treatment Improvement Protocol (TIP) Series No. 35]
  • Buglione S A, DeVito A J, Mulloy J M. Traditional group therapy and computer-administered treatment for test anxiety. Anxiety Res 1990; 3: 33–9
  • Carr A C, Ghosh A, Marks I M. Computer-supervised exposure treatment for phobias. Can J Psychiatry 1988; 33: 112–7
  • Ghosh A, Marks I M, Carr A C. Therapist contact and outcome of self-exposure treatment for phobias. A controlled study. Br J Psychiatry 1988; 152: 234–8
  • Selmi P M, Klein M H, Greist J H, Sorrell S P, Erdman H P. Computer-administered cognitive-behavioral therapy for depression. Am J Psychiatry 1990; 147: 51–6
  • Marsch L A, Bickel W K. Efficacy of computer-based HIV/AIDS education for injection drug users. Am J Health Behav 2004; 28: 316–27
  • Paperny D M, Aono J Y, Lehman R M, Hammar S L, Risser J. Computer-assisted detection and intervention in adolescent high-risk health behaviors. J Pediatr 1990; 116: 456–62
  • Winzelberg A J, Taylor C B, Sharpe T, Eldredge K L, Dev P, Constantinou P S. Evaluation of a computer-mediated eating disorder intervention program. Int J Eat Disord 1998; 24: 339–49
  • Winzelberg A J, Eppstein D, Eldredge K L, et al. Effectiveness of an Internet-based program for reducing risk factors for eating disorders. J Consult Clin Psychol 2000; 68: 346–50
  • White M A, Martin P D, Newton R L, et al. Mediators of weight loss in a family-based intervention presented over the internet. Obes Res 2004; 12: 1050–9
  • Frenn M. Peer leaders and adolescents participating in a multicomponent school based nutrition intervention had dietary improvements. Evid Based Nurs 2003; 6: 44
  • Frenn M, Malin S, Brown R L, et al. Changing the tide: an Internet/video exercise and low-fat diet intervention with middle-school students. Appl Nurs Res 2005; 18: 13–21
  • Berkowitz R I, Wadden T A, Tershakovec A M, Cronquist J L. Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial. JAMA 2003; 289: 1805–12
  • Sugerman H J, Wolfe L G, Sica D A, Clore J N. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 2003; 237: 751–6, discussion 757–8
  • Strauss R S, Bradley L J, Brolin R E. Gastric bypass surgery in adolescents with morbid obesity. J Pediatr 2001; 138: 499–504
  • Molnar D. New drug policy in childhood obesity. Int J Obes (Lond) 2005; 29(suppl 2)S62–5
  • Padwal R, Li S K, Lau D C. Long-term pharmacotherapy for obesity and overweight. Cochrane Database Syst Rev 2003, CD004094
  • Norgren S, Danielsson P, Jurold R, Lotborn M, Marcus C. Orlistat treatment in obese prepubertal children: a pilot study. Acta Paediatr 2003; 92: 666–70
  • Finer N. Present and future pharmacological approaches. Br Med Bull 1997; 53: 409–32
  • Ryan D H, Kaiser P, Bray G A. Sibutramine: a novel new agent for obesity treatment. Obes Res 1995; 3(suppl 4)553S–9S
  • James W P, Astrup A, Finer N, et al. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet 2000; 356: 2119–25
  • Wirth A, Krause J. Long-term weight loss with sibutramine: a randomized controlled trial. JAMA 2001; 286: 1331–9
  • Dujovne C A, Zavoral J H, Rowe E, Mendel C M. Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia. Am Heart J 2001; 142: 489–97
  • Finer N, Bloom S R, Frost G S, Banks L M, Griffiths J. Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study. Diabetes Obes Metab 2000; 2: 105–12
  • Kim S H, Lee Y M, Jee S H, Nam C M. Effect of sibutramine on weight loss and blood pressure: a meta-analysis of controlled trials. Obes Res 2003; 11: 1116–23
  • Guerciolini R. Mode of action of orlistat. Int J Obes Relat Metab Disord 1997; 21(suppl 3)S12–23
  • Sjostrom L, Rissanen A, Andersen T, et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet 1998; 352: 167–72
  • Heymsfield S B, Segal K R, Hauptman J, et al. Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults. Arch Intern Med 2000; 160: 1321–6
  • Rossner S, Sjostrom L, Noack R, Meinders A E, Noseda G. Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group. Obes Res 2000; 8: 49–61
  • Godoy-Matos A, Carraro L, Vieira A, et al. Treatment of obese adolescents with sibutramine: a randomized, double-blind, controlled study. J Clin Endocrinol Metab 2005; 90: 1460–5
  • Reisler G, Tauber T, Afriat R, Bortnik O, Goldman M. Sibutramine as an adjuvant therapy in adolescents suffering from morbid obesity. Isr Med Assoc J 2006; 8: 30–2
  • Berkowitz R I, Fujioka K, Daniels S R, et al. Effects of sibutramine treatment in obese adolescents: a randomized trial. Ann Intern Med 2006; 145: 81–90
  • McDuffie J R, Calis K A, Booth S L, Uwaifo G I, Yanovski J A. Effects of orlistat on fat-soluble vitamins in obese adolescents. Pharmacotherapy 2002; 22: 814–22
  • Ozkan B, Bereket A, Turan S, Keskin S. Addition of orlistat to conventional treatment in adolescents with severe obesity. Eur J Pediatr 2004; 163: 738–41
  • Shi Y F, Pan C Y, Hill J, Gao Y. Orlistat in the treatment of overweight or obese Chinese patients with newly diagnosed Type 2 diabetes. Diabet Med 2005; 22: 1737–43
  • Maahs D, de Serna D G, Kolotkin R L, et al. Randomized, double-blind, placebo-controlled trial of orlistat for weight loss in adolescents. Endocr Pract 2006; 12: 18–28
  • Chanoine J P, Hampl S, Jensen C, Boldrin M, Hauptman J. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. Jama 2005; 293: 2873–83
  • Hamilton J, Cummings E, Zdravkovic V, Finegood D, Daneman D. Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial. Diabetes Care 2003; 26: 138–43
  • Sarnblad S, Kroon M, Aman J. Metformin as additional therapy in adolescents with poorly controlled type 1 diabetes: randomised placebo-controlled trial with aspects on insulin sensitivity. Eur J Endocrinol 2003; 149: 323–9
  • Ibanez L, De Zegher F. Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception. J Clin Endocrinol Metab 2003; 88: 4720–4
  • Ibanez L, de Zegher F. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity. J Clin Endocrinol Metab 2004; 89: 1592–7
  • Arslanian S A, Lewy V, Danadian K, Saad R. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance. J Clin Endocrinol Metab 2002; 87: 1555–9
  • Schwimmer J B, Middleton M S, Deutsch R, Lavine J E. A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2005; 21: 871–9
  • Kay J P, Alemzadeh R, Langley G, D'Angelo L, Smith P, Holshouser S. Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Metabolism 2001; 50: 1457–61
  • Morrison J A, Cottingham E M, Barton B A. Metformin for weight loss in pediatric patients taking psychotropic drugs. Am J Psychiatry 2002; 159: 655–7
  • Srinivasan S, Ambler G R, Baur L A, et al. Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin. J Clin Endocrinol Metab 2006; 91: 2074–80
  • Garcia V F, Langford L, Inge T H. Application of laparoscopy for bariatric surgery in adolescents. Curr Opin Pediatr 2003; 15: 248–55
  • Inge T H. Bariatric surgery for morbidly obese adolescents: is there a rationale for early intervention?. Growth Horm IGF Res 2006; 16(suppl A)S15–9
  • American Academy of Pediatrics Committees on Nutrition and Gastroenterology (AAP). Weighing the consequences: bariatric surgery sometimes considered for obese children, but information lacking on long-term outcomes. AAP News 2003; 23: 16–8
  • Inge T H, Garcia V, Daniels S, et al. A multidisciplinary approach to the adolescent bariatric surgical patient. J Pediatr Surg 2004; 39: 442–7, discussion 446–7
  • Rand C S, Macgregor A M. Adolescents having obesity surgery: a 6-year follow-up. South Med J 1994; 87: 1208–13
  • Hodgkins C C, Cahill K S, Seraphine A E, Frost-Pineda K, Gold M S. Adolescent drug addiction treatment and weight gain. J Addict Dis 2004; 23: 55–65
  • Kirk S, Scott B J, Daniels S R. Pediatric obesity epidemic: treatment options. J Am Diet Assoc 2005; 105(5 suppl 1)S44–51

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.